Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -30.489% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
(a) Cc1nn(Cc2noc(C(=O)NC3CCC(C)CC3)n2)c(C)c1Br
(b) CC(=O)NC1CC2CCCC(C1)N2Cc1ccc(C)cc1
(c) [Cl-].c1ccc(C[n+]2cccc(-c3ccccc3)c2)cc1
(d) Clc1ccc(CNCc2cccs2)cc1Cl
Answer: b. CC(=O)NC1CC2CCCC(C1)N2Cc1ccc(C)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(=O)NC1CC2CCCC(C1)N2Cc1ccc(C)cc1
CC(=O)NC1CC2CCCC(C1)N2Cc1ccc(C)cc1
N-[9-[(4-methylphenyl)methyl]-9-azabicyclo[3.3.1]nonan-3-yl]acetamide